Whitehawk Therapeutics (WHWK) Leases: 2019-2024
Historic Leases for Whitehawk Therapeutics (WHWK) over the last 6 years, with Dec 2024 value amounting to $787,000.
- Whitehawk Therapeutics' Leases fell 32.68% to $787,000 in Q4 2024 from the same period last year, while for Dec 2024 it was $787,000, marking a year-over-year decrease of 32.68%. This contributed to the annual value of $787,000 for FY2024, which is 32.68% down from last year.
- Latest data reveals that Whitehawk Therapeutics reported Leases of $787,000 as of Q4 2024, which was down 11.17% from $886,000 recorded in Q3 2024.
- In the past 5 years, Whitehawk Therapeutics' Leases registered a high of $1.7 million during Q2 2022, and its lowest value of $9,452 during Q2 2021.
- For the 3-year period, Whitehawk Therapeutics' Leases averaged around $1.2 million, with its median value being $1.2 million (2023).
- Per our database at Business Quant, Whitehawk Therapeutics' Leases plummeted by 91.76% in 2021 and then surged by 17,388.36% in 2022.
- Quarterly analysis of 5 years shows Whitehawk Therapeutics' Leases stood at $119,000 in 2020, then spiked by 368.07% to $557,000 in 2021, then skyrocketed by 173.25% to $1.5 million in 2022, then decreased by 23.19% to $1.2 million in 2023, then tumbled by 32.68% to $787,000 in 2024.
- Its Leases stands at $787,000 for Q4 2024, versus $886,000 for Q3 2024 and $982,000 for Q2 2024.